phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gopalasingam, G; Herzog, H; Koller, J; Qi, Y; Zhang, L | 1 |
1 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Central NPFF signalling is critical in the regulation of glucose homeostasis.
Topics: Animals; Diabetes Mellitus, Type 2; Glucose; Homeostasis; Insulins; Mice; Oligopeptides | 2022 |